|
GB201915485D0
|
|
Improvements in or relaing to cognitive function
|
|
GB201720119D0
|
|
Prevention and/or treatment of neurodegenerative disease
|
|
GB201719969D0
|
|
Prevention and/or treatment of neurodegenerative disease
|
|
US2014187648A1
|
|
Identifying Subjects in Need of Treatment
|
|
GB201300055D0
|
|
Identifying subjects in need of treatment
|
|
CN103796717A
|
|
Improvements in or relating to visual performance and/or macular pigmentation
|
|
GB201207922D0
|
|
Improvements in or relating to visual performance and/or macular pigmentation
|
|
GB201207923D0
|
|
Improvements in or relating to visual performance
|
|
GB201111625D0
|
|
Improvements in or relating to visual performance
|
|
GB201111624D0
|
|
Improvements in or relating to visual performance and/or macular pigmentation
|
|
GB0411985D0
|
|
Food compositions containing creatine
|
|
MXPA05008903A
|
|
Compositions containing creatine, creatinine and a methyl xanthine.
|
